Published in Transplant Proc on March 01, 1977
Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg (1980) 1.45
The major histocompatibility complex--comparison in the mouse, man, and the rat. A review. Am J Pathol (1978) 0.87
Rapid mixed lymphocyte culture testing by analysis of the insulin receptor on alloactivated T lymphocytes: implications for human tissue typing. J Clin Invest (1981) 0.80
One-way stimulation in mixed leukocyte cultures. Science (1966) 6.62
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med (2000) 6.32
Histocompatibility matching. VI. Miniaturization of the mixed leukocyte culture test: a preliminary report. Transplantation (1971) 5.43
Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59
Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A (1980) 4.35
Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature (1976) 3.87
24-hour and 72-hour preservation of canine kidneys. Lancet (1967) 3.81
Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med (2000) 3.41
The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment. Transplant Proc (1973) 3.35
Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor. Cell Immunol (1972) 3.35
Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med (1973) 3.34
Hu-1: Major histocompatibility locus in man. Science (1967) 3.13
Cell mediated immunity: separation of cells involved in recognitive and destructive phases. Science (1973) 3.04
Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med (1968) 3.00
Extended preservation of the liver for clinical transplantation. Lancet (1988) 2.89
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem (1996) 2.79
Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J (1993) 2.75
Detection of a novel human class II HLA antigen. Nature (1983) 2.61
Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med (1998) 2.40
Genetic and immunological complexity of major histocompatibility regions. Science (1972) 2.40
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J Biol Chem (1996) 2.26
Cause of renal injury in kidneys obtained from cadaver donors. Surg Gynecol Obstet (1970) 2.20
Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. Transplantation (1993) 2.20
DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med (1991) 2.14
Role of H-2 lymphocyte-defined and serologically-defined components in the generation of cytotoxic lymphocytes. J Exp Med (1974) 2.01
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media. J Immunol Methods (1973) 1.97
RS-61443--a phase I clinical trial and pilot rescue study. Transplantation (1992) 1.97
Lymphocyte reactivity in vitro. I. Cellular reconstitution of purified lymphocyte response. Cell Immunol (1970) 1.97
The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med (1976) 1.92
HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes. Science (1975) 1.91
Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol (2001) 1.89
Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect Immun (1998) 1.87
Experience with reduced-size liver transplantation. Surg Gynecol Obstet (1990) 1.87
Preservation and transplantation of human cadaver kidneys: a two-year experience. Ann Surg (1970) 1.83
Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev (1977) 1.82
Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants. Nature (1985) 1.82
Etiology of rising perfusion pressure in isolated organ perfusion. Ann Surg (1968) 1.76
Lymphocyte reactivity in vitro. II. Soluble reconstituting factor permitting response of purified lymphocyte. Cell Immunol (1970) 1.74
Antigen-driven helper cell-independent cloned cytolytic T lymphocytes. Nature (1981) 1.72
Allogeneic and xenogeneic response in mixed leukocyte cultures. J Exp Med (1972) 1.70
Five HLA-D clusters associated with HLA-DR4. Hum Immunol (1982) 1.70
Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature (1976) 1.64
Specificity of allogeneic cell recognition by human lymphocytes in vitro. Science (1971) 1.62
Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62
Cell kinetic studies in mixed leukocyte cultures: an in vitro model of homograft reactivity. Proc Natl Acad Sci U S A (1969) 1.61
Lymphocyte studies in congenital thymic dysplasia: The one-way stimulation test. J Pediatr (1968) 1.59
Intestinal necrosis and perforation after renal transplantation. Arch Surg (1975) 1.59
The molecular basis of alloreactivity. Immunol Today (1990) 1.56
Use of HLA loss mutants to analyse the structure of the human major histocompatibility complex. Nature (1982) 1.56
Mouse cell-mediated lympholysis assay in serum-free and mouse serum-supplemented media: culture conditions and genetic factors. Scand J Immunol (1975) 1.55
72-hour preservation of the canine pancreas. Transplantation (1987) 1.55
Treatment of symptomatic gastroesophageal reflux using the Angelchik prosthesis. Ann Surg (1982) 1.53
Successful extrarenal transplantation from non-heart-beating donors. Transplantation (1995) 1.53
Successful seventeen-hour preservation and transplantation of human-cadaver kidney. N Engl J Med (1968) 1.52
Genetic control of cell-mediated lympholysis in mouse. J Exp Med (1974) 1.51
TCGF production for cloning and growth of functional human T lymphocytes. Scand J Immunol (1980) 1.50
Alternative pathways of T lymphocyte activation. J Exp Med (1978) 1.49
Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J Exp Med (1996) 1.49
Call for moratorium on xenotransplants. Nature (1998) 1.48
Specificity of antigen recognition by human lymphocytes in vitro. Science (1970) 1.48
Continuous culture of T cells cytotoxic for autologous human leukaemia cells. Nature (1979) 1.46
The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation (1991) 1.45
The correlation of MLC with graft survival. Transplant Proc (1973) 1.44
Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex. Nat New Biol (1973) 1.44
A ten year experience with cadaver kidney preservation using cryoprecipitated plasma. Am J Surg (1978) 1.44
Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model. J Infect Dis (1995) 1.43
Organ preservation. Annu Rev Med (1995) 1.43
Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes (2001) 1.43
Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J (2003) 1.42
Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. N Engl J Med (1990) 1.42
Dw/LD-related molecular polymorphism of DR4 beta-chains. J Exp Med (1983) 1.42
Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH). Clin Exp Immunol (1973) 1.41
Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells. Nature (1978) 1.41
Avascular necrosis of bone after renal transplantation. J Bone Joint Surg Am (1971) 1.40
SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines. Nature (1981) 1.40
Correlation between MLC stimulation and graft survival in living related and cadaver transplants. Ann Surg (1974) 1.36
Short term preservation of porcine livers. J Surg Res (1970) 1.34
Preservation of the canine liver for 24-48 hours using simple cold storage with UW solution. Transplantation (1988) 1.33
Experience with simultaneous pancreas-kidney transplantation. Ann Surg (1988) 1.32
Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation (1995) 1.32
Human lymphocytes recognise mouse alloantigens. Nature (1975) 1.31
Urological complications in 210 consecutive simultaneous pancreas-kidney transplants with bladder drainage. Ann Surg (1993) 1.31
Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem (1996) 1.30
Lipopolysaccharide-responder and nonresponder C3H mouse strains are equally susceptible to an induced Escherichia coli urinary tract infection. Infect Immun (1996) 1.29
Transplantation: pairing of donor and recipient. Science (1970) 1.28
The major histocompatibility complex - genetics and biology (third of three parts). N Engl J Med (1976) 1.28
A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood (1998) 1.27
Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta. J Immunol (1987) 1.26
Cytotoxicity: specificity after in vitro sensitization. Science (1970) 1.26
Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem (1995) 1.26
Thymic transplantation in a case of chronic mucocutaneous candidiasis. Lancet (1971) 1.26
Improved patient survival in renal transplantation. Surgery (1976) 1.25
Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation (1991) 1.24
NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. J Biol Chem (1994) 1.24
Important components of the UW solution. Transplantation (1990) 1.24
Specificity of cell-mediated lympholysis for public and private H-2 determinants. Scand J Immunol (1975) 1.24